G01N 2800/30
Psychoses
Official title: Psychoses; Psychiatry
G01N2800/30 (Psychoses) appears on 336 US grants and 738 published applications in this corpus.
Search patents in G01N- Granted patents
- 336
- Published applications
- 738
- Assignees
- 401
- Inventors
- 1,277
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 5 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 7 | 0 |
| 1999 | 5 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 2 | 5 |
| 2003 | 1 | 20 |
| 2004 | 5 | 18 |
| 2005 | 1 | 17 |
| 2006 | 4 | 24 |
| 2007 | 2 | 20 |
| 2008 | 8 | 33 |
| 2009 | 9 | 33 |
| 2010 | 16 | 33 |
| 2011 | 14 | 28 |
| 2012 | 15 | 38 |
| 2013 | 14 | 30 |
| 2014 | 15 | 50 |
| 2015 | 14 | 45 |
| 2016 | 23 | 45 |
| 2017 | 17 | 45 |
| 2018 | 20 | 36 |
| 2019 | 23 | 36 |
| 2020 | 27 | 33 |
| 2021 | 18 | 23 |
| 2022 | 15 | 30 |
| 2023 | 15 | 28 |
| 2024 | 12 | 27 |
| 2025 | 13 | 23 |
| 2026 | 4 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- G01N 2800/304Mood disordersIndexing code117
- G01N 2800/302SchizophreniaIndexing code99
- G01N 2800/307Drug dependencyIndexing code34
- G01N 2800/301Anxiety or phobic disordersIndexing code28
- G01N 2800/303Eating disordersIndexing code16
- G01N 2800/306Chronic fatigue syndromeIndexing code13
- G01N 2800/305Attention deficit disorderIndexing code10
- G01N 2800/308Psychosexual disordersIndexing code0
Recent patents
- Diagnostic methods for neural disorders15 Sep 2026US 12,736,528 B2Quiver Holdings Inc.
- Compliance method7 Jul 2026US 12,674,805 B2Nicoventures Trading Limited
- Compositions for restoring gene expression in neuropsychiatric or neurodegenerative disorders30 Jun 2026US 12,667,592 B2Immunotec Inc.
- Method for collecting extracellular vesicles derived from nervous system cells12 May 2026US 12,625,148 B2Osaka University
- Lactic acid bacteria and use thereof21 Oct 2025US 12,447,184 B1Navipharm Co., Ltd.
- Schizophrenia biomarker and method of diagnosis and kit of parts17 Sep 2026US 2026/0275418 A1Universidad AndréS Bello
- Targets and methods of diagnosing, monitoring and treating frontotemporal dementia17 Sep 2026US 2026/0276657 A1Arizona Board of Regents on behalf of Arizona State University
- Inhibition of zbtb7a30 Jul 2026US 2026/0216225 A1Icahn School of Medicine at Mount Sinai
- Biomarker for diagnosis of anxiety disorders and use thereof30 Jul 2026US 2026/0218300 A1Cha University Industry-Academic Cooperation Foundation
- Extracellular vesicles, isolation and use as biomarkers16 Jul 2026US 2026/0201469 A1The University of Newcastle
Most cited
By later US patents
- Colorimetric indicators for breath, air, gas and vapor analyses and method of manufacture115US 5,834,626 A1998
- Methods of identifying inverse agonists of the serotonin 2A receptor78US 6,358,698 B1Acadia Pharmacueticals Inc. · 2002
- System and method for diagnosis and treatment63US 8,658,128 B2Pop Test Cortisol LLC · 2014
- Method of treating psychosis and/or hyperactivity54US 6,013,621 AThe Rockfeller University · 2000
- Methods for drug discovery, disease treatment, and diagnosis using metabolomics45US 7,329,489 B2Cornell Research Foundation, Inc. · 2008